290 related articles for article (PubMed ID: 19605405)
1. The cell fate determination factor DACH1 is expressed in estrogen receptor-alpha-positive breast cancer and represses estrogen receptor-alpha signaling.
Popov VM; Zhou J; Shirley LA; Quong J; Yeow WS; Wright JA; Wu K; Rui H; Vadlamudi RK; Jiang J; Kumar R; Wang C; Pestell RG
Cancer Res; 2009 Jul; 69(14):5752-60. PubMed ID: 19605405
[TBL] [Abstract][Full Text] [Related]
2. Acetylation of the cell-fate factor dachshund determines p53 binding and signaling modules in breast cancer.
Chen K; Wu K; Gormley M; Ertel A; Wang J; Zhang W; Zhou J; Disante G; Li Z; Rui H; Quong AA; McMahon SB; Deng H; Lisanti MP; Wang C; Pestell RG
Oncotarget; 2013 Jun; 4(6):923-35. PubMed ID: 23798621
[TBL] [Abstract][Full Text] [Related]
3. Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells.
Zhang H; Xie X; Zhu X; Zhu J; Hao C; Lu Q; Ding L; Liu Y; Zhou L; Liu Y; Huang C; Wen C; Ye Q
J Biol Chem; 2005 Dec; 280(52):43188-97. PubMed ID: 16219765
[TBL] [Abstract][Full Text] [Related]
4. Estradiol-Induced MMP-9 Expression via PELP1-Mediated Membrane-Initiated Signaling in ERα-Positive Breast Cancer Cells.
Pan Y; Wang X; Zhang Y; Qiao J; Sasano H; McNamara K; Zhao B; Zhang D; Fan Y; Liu L; Jia X; Liu M; Song S; Wang L
Horm Cancer; 2020 Apr; 11(2):87-96. PubMed ID: 32037484
[TBL] [Abstract][Full Text] [Related]
5. Human glutathione S-transferase P1-1 functions as an estrogen receptor α signaling modulator.
Liu X; An BH; Kim MJ; Park JH; Kang YS; Chang M
Biochem Biophys Res Commun; 2014 Sep; 452(3):840-4. PubMed ID: 25218501
[TBL] [Abstract][Full Text] [Related]
6. Cell fate determination factor Dachshund reprograms breast cancer stem cell function.
Wu K; Jiao X; Li Z; Katiyar S; Casimiro MC; Yang W; Zhang Q; Willmarth NE; Chepelev I; Crosariol M; Wei Z; Hu J; Zhao K; Pestell RG
J Biol Chem; 2011 Jan; 286(3):2132-42. PubMed ID: 20937839
[TBL] [Abstract][Full Text] [Related]
7. Molecular cloning and characterization of PELP1, a novel human coregulator of estrogen receptor alpha.
Vadlamudi RK; Wang RA; Mazumdar A; Kim Y; Shin J; Sahin A; Kumar R
J Biol Chem; 2001 Oct; 276(41):38272-9. PubMed ID: 11481323
[TBL] [Abstract][Full Text] [Related]
8. Cloning and functional characterization of PELP1/MNAR promoter.
Mishra SK; Balasenthil S; Nguyen D; Vadlamudi RK
Gene; 2004 Apr; 330():115-22. PubMed ID: 15087130
[TBL] [Abstract][Full Text] [Related]
9. Modulation of in situ estrogen synthesis by proline-, glutamic acid-, and leucine-rich protein-1: potential estrogen receptor autocrine signaling loop in breast cancer cells.
Rajhans R; Nair HB; Nair SS; Cortez V; Ikuko K; Kirma NB; Zhou D; Holden AE; Brann DW; Chen S; Tekmal RR; Vadlamudi RK
Mol Endocrinol; 2008 Mar; 22(3):649-64. PubMed ID: 18079323
[TBL] [Abstract][Full Text] [Related]
10. PELP1 oncogenic functions involve CARM1 regulation.
Mann M; Cortez V; Vadlamudi R
Carcinogenesis; 2013 Jul; 34(7):1468-75. PubMed ID: 23486015
[TBL] [Abstract][Full Text] [Related]
11. Functional genomics identifies a mechanism for estrogen activation of the retinoic acid receptor alpha1 gene in breast cancer cells.
Laganière J; Deblois G; Giguère V
Mol Endocrinol; 2005 Jun; 19(6):1584-92. PubMed ID: 15831516
[TBL] [Abstract][Full Text] [Related]
12. Dach1, a vertebrate homologue of Drosophila dachshund, is expressed in the developing eye and ear of both chick and mouse and is regulated independently of Pax and Eya genes.
Heanue TA; Davis RJ; Rowitch DH; Kispert A; McMahon AP; Mardon G; Tabin CJ
Mech Dev; 2002 Feb; 111(1-2):75-87. PubMed ID: 11804780
[TBL] [Abstract][Full Text] [Related]
13. DACH1 is a cell fate determination factor that inhibits cyclin D1 and breast tumor growth.
Wu K; Li A; Rao M; Liu M; Dailey V; Yang Y; Di Vizio D; Wang C; Lisanti MP; Sauter G; Russell RG; Cvekl A; Pestell RG
Mol Cell Biol; 2006 Oct; 26(19):7116-29. PubMed ID: 16980615
[TBL] [Abstract][Full Text] [Related]
14. LKB1 catalytic activity contributes to estrogen receptor alpha signaling.
Nath-Sain S; Marignani PA
Mol Biol Cell; 2009 Jun; 20(11):2785-95. PubMed ID: 19369417
[TBL] [Abstract][Full Text] [Related]
15. Hakai acts as a coregulator of estrogen receptor alpha in breast cancer cells.
Gong EY; Park E; Lee K
Cancer Sci; 2010 Sep; 101(9):2019-25. PubMed ID: 20608937
[TBL] [Abstract][Full Text] [Related]
16. DACH1 inhibits transforming growth factor-beta signaling through binding Smad4.
Wu K; Yang Y; Wang C; Davoli MA; D'Amico M; Li A; Cveklova K; Kozmik Z; Lisanti MP; Russell RG; Cvekl A; Pestell RG
J Biol Chem; 2003 Dec; 278(51):51673-84. PubMed ID: 14525983
[TBL] [Abstract][Full Text] [Related]
17. A novel estradiol/estrogen receptor alpha-dependent transcriptional mechanism controls expression of the human prolactin receptor.
Dong J; Tsai-Morris CH; Dufau ML
J Biol Chem; 2006 Jul; 281(27):18825-36. PubMed ID: 16651265
[TBL] [Abstract][Full Text] [Related]
18. A transcriptional repressive role for epithelial-specific ETS factor ELF3 on oestrogen receptor alpha in breast cancer cells.
Gajulapalli VN; Samanthapudi VS; Pulaganti M; Khumukcham SS; Malisetty VL; Guruprasad L; Chitta SK; Manavathi B
Biochem J; 2016 Apr; 473(8):1047-61. PubMed ID: 26920025
[TBL] [Abstract][Full Text] [Related]
19. Apigenin inhibits antiestrogen-resistant breast cancer cell growth through estrogen receptor-alpha-dependent and estrogen receptor-alpha-independent mechanisms.
Long X; Fan M; Bigsby RM; Nephew KP
Mol Cancer Ther; 2008 Jul; 7(7):2096-108. PubMed ID: 18645020
[TBL] [Abstract][Full Text] [Related]
20. Estrogen induces expression of BCAS3, a novel estrogen receptor-alpha coactivator, through proline-, glutamic acid-, and leucine-rich protein-1 (PELP1).
Gururaj AE; Peng S; Vadlamudi RK; Kumar R
Mol Endocrinol; 2007 Aug; 21(8):1847-60. PubMed ID: 17505058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
